Key result
Ongoing reviews highlight TMVR devices for treating structural heart disease.
Key points are not available for this paper at this time.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Matt Gillespie (2016) studied this question. Transcatheter mitral valve replacement devices are the focus of ongoing updates and reviews for the treatment of structural heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: